title: Safe switch to beta-interferon treatment of chronic hepatitis C after alpha-interferon-induced autoimmune thrombocytopenia.
authors.forename: G
authors.initials: G
authors.lastname: Tappero
authors.forename: F
authors.initials: F
authors.lastname: Negro
authors.forename: M
authors.initials: M
authors.lastname: Farina
authors.forename: M
authors.initials: M
authors.lastname: Gallo
authors.forename: A
authors.initials: A
authors.lastname: Angeli
authors.forename: A
authors.initials: A
authors.lastname: Hadengue
mesh_terms: D001327:Autoimmune Diseases / Q000209:etiology*; D002908:Chronic Disease; D005260:Female; D006526:Hepatitis C / Q000628:therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use*; D019233:Retreatment; D013921:Thrombocytopenia / Q000209:etiology*
chemical_list: D016898:Interferon-alpha; D016899:Interferon-beta